ADT's unlocking features with Google Nest and Yale end, signaling a disappointing shift toward AT&T's new Connected Life platform. Tyler has worked on, lived with and tested all types of smart home ...

In a pooled analysis, longer duration of androgen deprivation therapy (ADT) was associated with nonlinear improvements in outcomes in men with prostate cancer receiving definitive radiotherapy.

TOKYO--(BUSINESS WIRE)--Mitsubishi Electric Corporation (TOKYO: 6503) announced today that its wholly owned subsidiary, Mitsubishi Electric Intelligent Manufacturing Technology (China) Group Co., Ltd.

ADT is a defensive, cash-generative business trading below intrinsic value, assuming it increases its ROIC. State Farm and Apollo, holding ~27% combined, may sell shares, potentially pressuring ADT’s ...

Google’s stock gained 60% year-to-date versus ADT’s 21%, suggesting markets favor AI providers over monitoring operators. ADT generates $1.10B from recurring monitoring with 25.7% operating margins.

Understand the difference between Data Types and Abstract Data Types (ADT) in this clear breakdown of data structure fundamentals. Learn how they are defined, how they work, and why ADTs are essential ...

In men with hormone-sensitive metachronous oligometastatic prostate cancer, the use of stereotactic body radiotherapy (SBRT) commonly delayed the need for long-term ADT and provided durable disease ...

Patients who received ADT for 3 months or 9 months had worse overall survival than those treated for 36 months. For men with prostate cancer treated with definitive radiotherapy, the benefit derived ...

ADT delivered solid Q3 performance with higher earnings, cash flow and installation revenue driven by ADT+. Attrition ticked up, but management expects improvement in early 2026 as customer experience ...

BOCA RATON, Fla. — ADT entered the second half of 2025 with 4% total revenue growth, amid a slight dip in recurring monthly revenue (RMR), but the company remains confident in the strength of its ...

Androgen deprivation therapy (ADT), also called hormone therapy, is a common treatment for metastatic prostate cancer. It works by starving the cancer of testosterone, which fuels the tumor’s growth.